LINC02426

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LINC02426 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02426 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC02426 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02426 expression acts as an unfavorable survival marker.

KIRC, STAD, and THCA are the cancer types where LINC02426 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCOSTertileAll0.4960.669<.001134view →
STADOSTertileII,III,IV0.4960.750.00492view →
THCAOSTertileAll0.7890.950<.00181view →
PAADOSTertileII,III,IV0.3830.568<.00163view →
OVOSTertileIV0.0760.759.01436view →
LUSCDFSTertileIII,IV0.1840.662.01027view →
SARCDFSTertileAll0.2530.569.00127view →
SKCMDFSTertileII,III,IV0.1920.598.00418view →
KICHOSTertileAll0.6480.972.0129view →
THYMDFSTertileAll0.7010.917.0343view →
Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02426–KIRC (OS)

Kaplan–Meier survival curve for LINC02426 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration